Pseudoscience: How Big Pharma Cooks the Books in the Scientific Journals
When David Sinclair’s company started clinical trials on the health benefits of reverse ageing through manipulation of genes, big pharma published critical articles on his approach and the FDA shut down his clinical trials. Fortunately, David did not capitulate to corporate manipulation of the scientific journals.
Time Magazine Recognizes Dr. David Sinclair for His Work On Nad+ and Resveratrol’s Contribution to Human Health and Disease Prevention.
Dr. Jonathan Wright reports:
The extent of published research on the phytochemical resveratrol is impressive and growing all the time, with now more than 6000 studies reported. This pharmacologically promiscuous compound demonstrates an amazing array of favorable health outcomes, such as cardioprotective, antidiabetic, anticancer, antiviral, neuroprotective, antiplatelet, anti-inflammatory and modulation of fat metabolism. More importantly, the development of major chronic diseases might also be reduced by resveratrol, based on laboratory studies, including cardiovascular disease, dementia, type 2 diabetes and osteoarthritis. This is in addition to its touted effect on holding back the aging process via SIRT1, implying that this one simple molecule has the potential to help prevent most of the chronic diseases associated with old age. For more see Nutrition and Healing, Volume 21, Issue 5, August 2014.